BREVE 23 - FAILURES IN THE GENERIC MEDICATION MARKET IN CHILE AND RECOMMENDATIONS TO IMPROVE COMPETITION
Type of publication:
Breves
Publication date:
Descripción

This brief presents a summary of the main findings of the study presented in the Technical Note, "Failures in the generic medicines market in Chile and recommendations to improve competition"Failures in the generic medicines market in Chile and recommendations to improve competition competition". This study analyzes the generic medicines market and its level of competition in Chile. Despite the benefits generated by the existence and availability of generics in the market once the patent expires, in practice, the functioning of the generic medicines market medicines present flaws that limit the levels of competition. This publication investigates the causes that limit competition and their effect on the final price faced by consumers. To propose concrete public policy recommendations for the Chilean context. The study presents three analyzes quantitative measures of market concentration: at the household level, at the level of public purchases and at the level of pharmacies. Based on the results obtained and a qualitative analysis of interviews with key actors, recommendations emerge that are classified around a macro or systemic level and according to actor: distributors, prescribers and patients. Beyond the fact that each one presents its own particularities, to achieve efficiency in public and private spending on medicines requires collective efforts and complementary policies between the different levels of the market.

Authors: Paúl Rodriguez; Bárbara Flores
SEE PUBLICATION